{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:09:27Z","timestamp":1789578567626,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Total body irradiation (TBI) is the cornerstone of conditioning regimens in pediatric hematopoietic stem cell transplantation for acute lymphoblastic leukemia. As the late effects and survival comparison between TBI and chemotherapy were well analyzed before, in this study, we aim to focus on the first 100 days and early complications of transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective study involves 72 pediatric patients (0 to 18\u2009y) underwent first hematopoietic stem cell transplantation for acute lymphoblastic leukemia between October 2015 and May 2019. Patients are divided into 2 groups regarding conditioning regimens. Conditionings includes either TBI 1200\u2009cGy\/6 fractions\/3 days and etoposide phosphate or busulfan, fludarabine, and thiotepa. Busulfan was administered IV and according to body weight.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The incidences of acute graft versus host disease grade 2 to 4, veno-occlusive disease, capillary leakage syndrome, thrombotic microangiopathy, blood stream infection, hemorrhagic cystitis and posterior reversible encephalopathy syndrome before day 100 were similar for both conditioning regimens; however, patients received TBI-based conditioning had significantly longer neutrophil engraftment time (17.5 vs. 13\u2009d, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001) and tended to have more engraftment syndrome (ES) (45.5% for TBI vs. 24.0% for chemotherapy, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.069). Multivariate analysis showed that TBI-based conditioning was associated with a longer neutrophil engraftment time (hazard ratio [HR]=1.20, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.006), more cytomegalovirus (CMV) reactivation (HR=3.65, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.038) and more ES (HR=3.18, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.078).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our findings support chemotherapy-based regimens with early neutrophil engraftment, less ES and CMV reactivation compared with TBI. Although there is no impact on survival rates, increased incidence of ES and CMV reactivation should be considered in TBI-based regimens.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002055","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:34:12Z","timestamp":1614386052000},"page":"266-270","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of Total Body Irradiation\u2013based Versus Chemotherapy-based Conditionings for Early Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Children With ALL"],"prefix":"10.1097","volume":"43","author":[{"given":"Koray","family":"Yalcin","sequence":"first","affiliation":[{"name":"MedicalPark Goztepe Hospital, Pediatric Bone Marrow Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berrin","family":"Pehlivan","sequence":"additional","affiliation":[{"name":"Bahcesehir University Faculty of Medicine, Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Celen","sequence":"additional","affiliation":[{"name":"MedicalPark Goztepe Hospital, Pediatric Bone Marrow Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Gulsah","family":"Bas","sequence":"additional","affiliation":[{"name":"Bahcesehir University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Kabakci","sequence":"additional","affiliation":[{"name":"Bahcesehir University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayanat","family":"Pashayev","sequence":"additional","affiliation":[{"name":"MedicalPark Goztepe Hospital, Pediatric Bone Marrow Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayriye","family":"Daloglu","sequence":"additional","affiliation":[{"name":"MedicalPark Antalya Hospital, Pediatric Bone Marrow Transplantation Unit, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman","family":"Zhumatayev","sequence":"additional","affiliation":[{"name":"MedicalPark Goztepe Hospital, Pediatric Bone Marrow Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Uygun","sequence":"additional","affiliation":[{"name":"MedicalPark Antalya Hospital, Pediatric Bone Marrow Transplantation Unit, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsun Tezcan","family":"Karasu","sequence":"additional","affiliation":[{"name":"MedicalPark Goztepe Hospital, Pediatric Bone Marrow Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Hazar","sequence":"additional","affiliation":[{"name":"MedicalPark Goztepe Hospital, Pediatric Bone Marrow Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif","family":"Yesilipek","sequence":"additional","affiliation":[{"name":"MedicalPark Goztepe Hospital, Pediatric Bone Marrow Transplantation Unit"},{"name":"MedicalPark Antalya Hospital, Pediatric Bone Marrow Transplantation Unit, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM197406202902501","article-title":"Bone-marrow transplantation for hematologic neoplasia in 16 patients with identical twins","volume":"290","author":"Fefer","year":"1974","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"R2-20250804","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/bmt.2008.47","article-title":"Current European practice in pediatric myeloablative conditioning","volume":"41","author":"Vettenranta","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/pbc.24702","article-title":"Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years","volume":"60","author":"Kunkele","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"suppl 2","key":"R4-20250804","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00066-009-1008-x","article-title":"Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies","volume":"185","author":"Ricardi","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ijrobp.2005.04.031","article-title":"Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant","volume":"63","author":"Faraci","year":"2005","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00066-010-2089-2","article-title":"Total body irradiation (TBI) in pediatric patients. a single-center experience after 30 years of low-dose rate irradiation","volume":"186","author":"Linsenmeier","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","article-title":"Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study","volume":"32","author":"Bunin","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/10428190903419130","article-title":"Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis","volume":"51","author":"Shi-Xia","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3109\/10428194.2013.779691","article-title":"Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant","volume":"54","author":"Eroglu","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Int Med"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/petr.12831","article-title":"Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study","volume":"20","author":"Lucchini","year":"2016","journal-title":"Pediatr Transplant"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","article-title":"Graft failure after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Ozdemir","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000430489","article-title":"Clinical management of posterior reversible encephalopathy syndrome after allogeneic hematopoietic stem cell transplantation: a case series and review of the literature","volume":"135","author":"Schmidt","year":"2016","journal-title":"Acta Haematol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0090-4295(82)90633-1","article-title":"Prevention of cyclophosphamide-induced hemorrhagic cystitis","volume":"20","author":"Droller","year":"1982","journal-title":"Urology"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08880018.2019.1591549","article-title":"The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010)","volume":"36","author":"Freycon","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/bmt.2015.278","article-title":"Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT","volume":"51","author":"Cahu","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbmt.2015.12.016","article-title":"Cytokine profile of engraftment syndrome in pediatric hematopoietic stem cell transplant recipients","volume":"22","author":"Khandelwal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V83.8.2360.2360","article-title":"Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice","volume":"83","author":"Xun","year":"1994","journal-title":"Blood"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-8140(99)00178-4","article-title":"Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation","volume":"54","author":"Buchali","year":"2000","journal-title":"Radiother Oncol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbmt.2014.05.022","article-title":"Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes","volume":"20","author":"Chang","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R25-20250804","first-page":"16","article-title":"Engraftment syndrome: an updated review","volume":"1","author":"Mutahar","year":"2017","journal-title":"J Stem Cell Biol Transplant"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/bmt.2016.89","article-title":"Impact of early CMV reactivation in cord blood stem cell recipients in the current era","volume":"51","author":"Ramanathan","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.V97.4.867","article-title":"Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes","volume":"97","author":"Nichols","year":"2001","journal-title":"Blood"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.mehy.2014.02.022","article-title":"Posterior reversible encephalopathy syndrome: the endothelial hypotheses","volume":"82","author":"Marra","year":"2014","journal-title":"Med Hypotheses"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.bbmt.2007.07.013","article-title":"Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance","volume":"13","author":"Siegal","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1634\/theoncologist.2014-0149","article-title":"Posterior reversible encephalopathy syndrome in patients with cancer","volume":"20","author":"Singer","year":"2015","journal-title":"Oncologist"},{"key":"R31-20250804","first-page":"1060","article-title":"Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation","volume":"85","author":"Granados","year":"2000","journal-title":"Haematologica"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:09:46Z","timestamp":1754338186000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002055","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"2020-09-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}